Skip to main content
Equibles

Opaleye Management Inc.

Position in URGN — UroGen Pharma Ltd.

CIK 1595855 Boston, MA
Back to URGN Full portfolio

Position in URGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$52,991,852
+$27,280,452 QoQ
Shares Held
1,439,996
+0.7% QoQ
Ownership
2.95%
of shares outstanding
% of Portfolio
4.86%
of 13F equity value
Holder Rank
#11
of 190 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Opaleye Management Inc. holds $678,840,611 across 50 Biotechnology names. URGN ranks #2 (7.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IRON
Disc Medicine, Inc.
 855,000 $62,534,700
2 URGN
UroGen Pharma Ltd.
This page 		1,439,996 $52,991,852
3 APGE
Apogee Therapeutics, Inc.
 390,000 $51,764,700
4 MGTX
MeiraGTx Holdings plc
 3,550,000 $47,960,500
5 SLGL
Sol-Gel Technologies Ltd.
 500,000 $37,070,000
6 RZLT
Rezolute, Inc.
 6,300,000 $32,760,000
7 TGTX
Tg Therapeutics, Inc.
 535,000 $29,392,900
8 IMMX
Immix Biopharma, Inc.
 2,345,000 $24,176,950

All Filings in URGN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $52,991,852 1,439,996
2026-03-31 $25,711,400 1,430,000
2025-12-31 $6,286,466 268,423
2024-12-31 $2,343,000 220,000
2024-09-30 $5,132,070 404,100
2024-06-30 $6,913,360 412,000
2024-03-31 $4,050,000 270,000
2023-12-31 $4,800,000 320,000
2023-09-30 $4,483,200 320,000
2023-06-30 $5,899,500 570,000
2023-03-31 $4,666,200 505,000
2022-12-31 $4,334,378 488,656
2022-09-30 $3,307,200 397,500
2022-06-30 $1,954,707 238,670